Head-to-head · WeighScore
DoctorAdam vs NuuVim
The verdict
DoctorAdam takes it — 75.9/100 to 68.2/100.
DoctorAdam grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DoctorAdam is a Shopify-based telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral tablet forms, with flat all-in monthly pricing covering physician evaluation,…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | DoctorAdam | NuuVim |
|---|---|---|
| WeighScore | 75.9/100 | 68.2/100 |
| Grade | C | C |
| Scorecard rank | #54 | #153 |
| Semaglutide | $129/mo (starting dose, compounded) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide | $229/mo (starting dose, compounded) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Coverage | 44 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #54 · C
Strengths
- Offers both injection and oral tablet forms of compounded semaglutide and tirzepatide
- Flat all-in pricing — physician evaluation, medication, and free shipping included
- Named pharmacy partners: Olympia Pharmaceuticals (Orlando, FL) and Carie Boyd Pharmaceuticals (Irving, TX)
- LegitScript certified with 4.8/5 Trustpilot score from 5,400+ reviews and 100K+ patients
- No hidden fees, no required recurring commitment, full refund if not prescribed
Where it loses points
- Compounded medications are not FDA-approved individual drugs
- No labs or dedicated coaching disclosed on public pages
- Only 44 states served — AK, MA, MS, NJ, RI, and VT excluded despite homepage '50 states' claim
- Dose-tier pricing not published; only starting prices visible without quiz
- Shopify-based store rather than a dedicated health platform
Graded #153 · C
Strengths
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
Where it loses points
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
- The site's own llms.txt advertises pricing, FAQ and terms files that all 404
- No state count is published
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.